We read with great interest the recent article by Gerriets and colleagues 1 dealing with the neuroprotective effects of MK-801, the N-methyl-D-aspartate (NMDA) receptor antagonist, in the different rat stroke models for the permanent middle cerebral artery occlusion (MCAO). The results of their presented study demonstrated that, because hypothalamic damage and subsequent hyperthermia can confound the results, the macrosphere MCAO models without hypothalamic damage may be more appropriate to study the neuroprotective effects of MK-801 than the suture MCAO and the macrosphere MCAO models with hypothalamic infarction.
Response: Neuroprotective Effects of MK-801 and Catecholamine Release in the Central Nervous System
Dr Tsuda reported interesting observations from in vitro and in vivo experiments, suggesting a 2nd neuroprotective effect of MK-801 (besides NMDA antagonism) that is based on sympatholytic effects of this drug. Our recent paper indicates that MK-801 is significantly less (or not) effective if animal models for permanent middle cerebral artery occlusion (MCAO) are applied that do not avoid hypothalamic damage with subsequent hyperthermia. 1,2 However, the release of norepinephrine or glutamate within the affected hemisphere has not been analyzed in our experiments. We agree that further studies of catecholamine and glutamate release in different models would be highly interesting in this context. One can speculate whether hypothalamic damage and artificial hyperthermia (which are typical complications of the suture-MCAO model) might affect the release of glutamate or norepinephrine (or both) in the injured hemisphere and thus can contribute to the confounding effects of hypothalamic infarction on neuroprotective drug studies. We have no good explanation for the depletion of dopamine and noradrenaline levels in the hemisphere affected by microsphere injection into the carotid artery as performed in the experiments of Bralet and coworkers in 1980. 3 However, the microsphere model that was used in this study typically consists of the injection of hundreds or thousands of very small particles blocking the cerebral microcirculation. Our new macrosphere model, in contrast, consists of the embolization of only 6 large spheres leading to an occlusion of the MCA mainstem, similar to the suture technique. We would like to place particular emphasis on this important difference between the microsphere and the macrosphere model.
